Advertisement

Glucagon-Like Peptide-1 Receptor Agonists May Reduce Alcohol Consumption

0

However, authors caution there is little high-quality evidence

Four Million Americans Could Lose Health Coverage Once ACA Credits Expire

0
By Carole Tanzer Miller HealthDay Reporter WEDNESDAY, Nov. 20, 2024 (HealthDay News) -- If Congress lets health care tax credits established during the pandemic expire,...

ACR: Colchicine No Benefit for Painful Knee Osteoarthritis

0

No significant improvements seen in knee pain, function, or size of synovial effusions versus placebo

Judge Declares Wyoming’s Abortion Bans Unconstitutional

0
By Robin Foster HealthDay Reporter TUESDAY, Nov. 19, 2024 (HealthDay News) -- Two Wyoming abortion bans, including the first state law to prohibit the use...

President-Elect Trump to Pick Mehmet Oz to Head CMS

0

Oz worked as a heart surgeon before helming a hugely successful daytime talk show, focused on health and medicine

Antiviral Treatment Underutilized for Children, Teens With Flu

0

Since 2017 to 2018 season, there has been a decrease in the proportion of hospitalized children receiving antiviral treatment

Barriers to Widespread Access to Cancer Medications Include Excessive Cost

0

Solutions to address inequity in drug distribution include sharing production secrets, international funding, cost-effective screening

Risk for Emergently Treated Hypocalcemia With Denosumab Rises With CKD Stage

0

Risk increased with worsening CKD stage with denosumab versus bisphosphonates; highest risk seen for dialysis-dependent CKD, CKD-mineral and bone disorder

ACR: Inebilizumab Reduces Risk for Flares in IgG4-Related Disease

0

Flare-free, treatment-free complete remission and flare-free, glucocorticoid-free complete remission improved with inebilizumab

Oral Infigratinib Seems Safe for Children With Achondroplasia

0

At dose of 125 mg/kg body weight, oral infigratinib results in increased annualized height velocity and z score